Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Tuberculosis

  Free Subscription


21.11.2022

1 AIDS
1 Antimicrob Agents Chemother
1 J Infect
2 Lancet
7 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. MITINI-NKHOMA SC, Mzinza DT, Chimbayo ET, Chirambo AP, et al
    Latent tuberculosis infection among adults attending HIV services at an urban tertiary hospital in Malawi.
    AIDS. 2022;36:2229-2231.
    PubMed        


    Antimicrob Agents Chemother

  2. LYONS MA
    Pharmacodynamics and Bactericidal Activity of Combination Regimens in Pulmonary Tuberculosis: Application to Bedaquiline-Pretomanid-Pyrazinamide.
    Antimicrob Agents Chemother. 2022 Nov 15:e0089822. doi: 10.1128/aac.00898.
    PubMed         Abstract available


    J Infect

  3. CALDERWOOD CJ, Reeve BW, Mann T, Palmer Z, et al
    Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults.
    J Infect. 2022 Nov 11. pii: S0163-4453(22)00639.
    PubMed         Abstract available


    Lancet

  4. GOODALL RL, Meredith SK, Nunn AJ, Bayissa A, et al
    Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
    Lancet. 2022 Nov 7. pii: S0140-6736(22)02078.
    PubMed         Abstract available

  5. DHEDA K, Lange C
    A revolution in the management of multidrug-resistant tuberculosis.
    Lancet. 2022 Nov 7. pii: S0140-6736(22)02161.
    PubMed        


    PLoS One

  6. KIM HB, Bacik JP, Wu R, Jha RK, et al
    Label-free affinity screening, design and synthesis of inhibitors targeting the Mycobacterium tuberculosis L-alanine dehydrogenase.
    PLoS One. 2022;17:e0277670.
    PubMed         Abstract available

  7. MESHESHA MD
    Predictors of sputum culture conversion time among MDR/RR TB patients on treatment in a low-income setting.
    PLoS One. 2022;17:e0277642.
    PubMed         Abstract available

  8. BAIRD K, Said H, Koornhof HJ, Duse AG, et al
    Tuberculosis control at a South African correctional centre: Diagnosis, treatment and strain characterisation.
    PLoS One. 2022;17:e0277459.
    PubMed         Abstract available


  9. Expression of Concern: Secretory Phosphatases Deficient Mutant of Mycobacterium tuberculosis Imparts Protection at the Primary Site of Infection in Guinea Pigs.
    PLoS One. 2022;17:e0277782.
    PubMed        

  10. COCCIA M, Burny W, Demoitie MA, Gillard P, et al
    Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.
    PLoS One. 2022;17:e0276505.
    PubMed         Abstract available

  11. RODRIGUEZ CA, Lodi S, Horsburgh CR, Bastard M, et al
    Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion.
    PLoS One. 2022;17:e0276457.
    PubMed         Abstract available

  12. HUDDART S, Geocaniga-Gaviola DM, Crowder R, Lim AR, et al
    Adherence trajectory as an on-treatment risk indicator among drug-resistant TB patients in the Philippines.
    PLoS One. 2022;17:e0277078.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: